Gilead Sciences, Inc. is 10% Owner at ASSEMBLY BIOSCIENCES, INC. (ASMB). They have made 8 open-market trades across 5 companies since 2023, most recently 2026-05-26.
8 open-market purchases totalling $440.7M since 2023, never a sale. Across 8 scored buys the stock is down 26.9% at ninety days, and 26.5 points behind the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 25% | 0% |
| Avg Move | -0.6% | -2.0% | -26.9% |
| Alpha | -0.5% | -3.8% | -26.5% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RCUS | BUY | 2025-02-18 | 2025-02-20 | $11.00 | $15.0M | -15.7% | -20.7% | -25.1% |
| ASMB | BUY | 2024-12-19 | 2024-12-23 | $21.37 | $40.2M | +13.4% | -2.3% | -27.3% |
| XLO | BUY | 2024-12-18 | 2024-12-19 | $1.04 | $3.7M | +0.9% | +19.8% | -25.1% |
| XLO | BUY | 2024-04-02 | 2024-04-03 | $0.76 | $369K | -3.8% | -9.9% | -32.1% |
| KYTX | BUY | 2024-02-12 | 2024-02-13 | $22.00 | $20.0M | -7.4% | -2.4% | -51.7% |
| RCUS | BUY | 2024-01-29 | 2024-01-31 | $21.00 | $320.0M | +3.4% | +20.0% | -4.3% |
| RCUS | BUY | 2023-06-28 | 2023-06-30 | $19.26 | $19.5M | +11.1% | -2.5% | -11.5% |
| ALVR | BUY | 2023-06-27 | 2023-06-28 | $3.75 | $22.0M | -6.6% | -17.6% | -37.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.